Pre-clinical studies have examined the interplay between radiation and anti-CD47 therapy in SCLC mouse models as radiation therapy is commonly used in conjunction with systemic therapies for both palliative and curative purposes in SCLC [72]. The gene discussed is CD47; the disease is small cell lung carcinoma.